Boulder Hill Capital Management’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,900	Closed	-$226K	–	86
2023 Q1	$226K	Buy	+5,900	New	+$226K	0.18%	103